Skip to main content
SpringerLink
Log in

Die Kombination von Antidepressiva und Neuroleptika bei der Behandlung der Schizophrenie

  • Chapter
Kombination therapeutischer Strategien bei schizophrenen Erkrankungen

Zusammenfassung

In den letzten Jahren ist das Problem des gleichzeitigen Vorhandenseins depressiver und schizophrener Symptome komplexer geworden — oder soll man sagen interessanter aufgrund des wachsenden Interesses an sogenannten »negativen Symptomen« der Schizophrenie.

Für die Übertragung aus dem Englischen verantwortlich: Dr. F. Kulhanek, München, und Oberärztin Dr. R. Neumann, Innsbruck.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Andreasen, NC, Olsen S. Negative vs positive schizophrenia: Definition and validation. Arch Gen Psychiatry 1982; 39: 789–794.

    Article  PubMed  Google Scholar 

  • Crow TJ. Molecular pathology of schizophrenia: More than one disease process? Br Med J 1980; 280: 66–68.

    Article  PubMed Central  PubMed  Google Scholar 

  • Csernansky JG, Lombrozo L, Gulevich GD, et al. Treatment of negative schizophrenic symptoms with alprazolam: A preliminary open-label study. J Clin Psychopharmacol 1984; 4: 349–352.

    Article  PubMed  Google Scholar 

  • Glassman AH, Perel JM, Shostak M, et al. Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 1977; 34: 197–204.

    Article  PubMed  Google Scholar 

  • Gram I Peisby N, Ibsen I, et al Plasma levels and antidepressive effect of imipramine Clin Pharmacol Ther 1976; 19:318–324.

    Google Scholar 

  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.

    Article  PubMed  Google Scholar 

  • Mandel MR Severe JB Schooler NR, et al. Development and prediction of post-psychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry 1982; 39:197–203.

    Google Scholar 

  • Mcglashan TH, Carpenter WT Jr. Post-psychotic depression in schizophrenia. Arch Gen Psychiatry 1976; 33: 231–241.

    Article  Google Scholar 

  • Putten Van T May Pra. »Akinetic depression« in schizophrenia. Arch Gen Psychiatry 1978; 35:1101–1107.

    Google Scholar 

  • Rifkin, A, Quitkin F, Klein DF. Akinesia. Arch Gen Psychiatry 1975; 32: 672–674.

    Article  Google Scholar 

  • Rifkin A, Quitkin F, Kane J, et al. Are prophylactic antiparkinson drugs necessary? Arch Gen Psychiatry 1978; 35: 483–489.

    Article  PubMed  Google Scholar 

  • Roy A. Suicide in chronic schizophrenia. Br J Psychiatry 1982a; 141: 171–177.

    Article  PubMed  Google Scholar 

  • Roy A. Risk factors for suicide in psychiatric patients. Arch Gen Psychiatry 1982b; 39: 10891095.

    Google Scholar 

  • Siris SG, Glassman AH, Stetner F. The value of plasma concentrations in assessing the effects of tricyclic antidepressants. In: Schooler JC, Claghorn JL, eds. Kinetics of Psychiatric Drugs. New York: Brunner-Mazel, 1979: 215–223.

    Google Scholar 

  • Siris SG, Harmon GK, Endicarr J. Post-psychotic depressive symptoms in hospitalized schizophrenic patients. Arch Gen Psychiatry 1981; 81: 1122–1123.

    Article  Google Scholar 

  • Siris SG, Kammen Van DP, Docherty JP. Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry 1978; 35: 1368–1377.

    Article  PubMed  Google Scholar 

  • Siris SG, Morgan V, Fagerstrom R, et al. Adjunctive imipramine in the treatment of post-psychotic depression: A controlled trial. Arch Gen Psychiatry 1987; 44: 533–539.

    Article  PubMed  Google Scholar 

  • Siris SG, Rifkin A. Drug treatment of depression in patients with schizophrenia. In: RIFKIN A, ed. Schizophrenia and Depression: Biology and Drug Treatment. Boston: PSG—John Wright, 1983: 281–297.

    Google Scholar 

  • Siris Sg, Rifkin A, Reardon Gt, et al. The dexamethasone suppression test in patients with post-psychotic depression. Biol Psychiatry 1984; 19: 1351–1356.

    PubMed  Google Scholar 

  • Spitzer Rl, Endiwtt J, Robins E. Research Diagnostic Criteria: Rationale and reliability. Arch Gen Psychiatry 1978; 35: 773–782.

    Google Scholar 

  • Tsuang Mt. Suicide in schizophrenics, manics, depressives, and surgical controls. Arch Gen Psychiatry 1978; 35: 153–155.

    Article  PubMed  Google Scholar 

  • Wilkinson DG. The suicide rate in schizophrenia. Br J Psychiatry 1982; 140: 138–141.

    Article  PubMed  Google Scholar 

  • Wolkowitz OM, Pickar D, Doran AR, et al. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. Am J Psychiatry 1986; 142: 85–87.

    Google Scholar 

Download references

Authors
  1. A. Rifkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. G. Siris
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinik für Psychiatrie, Anichstraße 35, A-6020, Innsbruck, Österreich

    H. Hinterhuber  & W. W. Fleischhacker  & 

  2. Squibb-von Heyden, Volkartstraße 83, D-8000, München 19, Deutschland

    F. Kulhanek (Leiter der Abt. Psychopharmaka) (Leiter der Abt. Psychopharmaka)

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Friedr. Vieweg Verlag, Braunschweig/Wiesbaden

About this chapter

Cite this chapter

Rifkin, A., Siris, S.G. (1990). Die Kombination von Antidepressiva und Neuroleptika bei der Behandlung der Schizophrenie. In: Hinterhuber, H., Kulhanek, F., Fleischhacker, W.W. (eds) Kombination therapeutischer Strategien bei schizophrenen Erkrankungen. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-01924-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-01924-4_3

  • Publisher Name: Vieweg+Teubner Verlag, Wiesbaden

  • Print ISBN: 978-3-663-01925-1

  • Online ISBN: 978-3-663-01924-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation